A comprehensive study of the pharmaceutical material industry focusing on 38 selected chemical companies
Custom Synthesis Business for Life Science Industries in Japan
Outline of the report
Comprehensive study was carried out in order to provide deep insights into the strategic business of active ingredients and intermediates manufacturers in Japan - from medium- to large-scale companies - offering custom synthesis services to leading international pharmaceutical companies.
Technological competence as well as both current and potential production capacities of each company are highlighted, with a particular focus on their competitiveness in the international market in terms of cost, product quality, environmental impact, and strengths in organic synthesis, biosynthesis and combined technology to manufacture chiral compounds.
The Product Lists contain specific types of custom synthesis being made available from each company surveyed, along with chemical structure of the compounds, pharmaceutical companies using those substances, and the drugs for which those materials are used.
Technological competence as well as both current and potential production capacities of each company are highlighted, with a particular focus on their competitiveness in the international market in terms of cost, product quality, environmental impact, and strengths in organic synthesis, biosynthesis and combined technology to manufacture chiral compounds.
The Product Lists contain specific types of custom synthesis being made available from each company surveyed, along with chemical structure of the compounds, pharmaceutical companies using those substances, and the drugs for which those materials are used.
| Title of the report | Custom Synthesis Business for Life Science Industries in Japan |
| Date of issue | 03/07/03 |
| Volume | A4 / 269 pages |
| Price | 200,000JPY |
| Produced by | Seed Planning, Inc. |
| Note | $ 1,995 for orders from outside Japan |
| Category | Pharmaceutical materials / vendors |
Details of the report
Companies surveyed
Ajinomoto Co., Inc. API Corporation Asahi Glass Co., Ltd. Central Glass Co.,Ltd. Chisso Corporation Daicel Chemical Industries, Ltd. Daiichi Fine Chemicals Co., Ltd. Daikin Industries, Ltd. Daiso Co., Ltd. Hokko Chemical Industry Co., Ltd. Ihara Chemical Industry Co., Ltd. Kaneka Chemical Industry, Co. Ltd. Koei Chemical Co., Ltd. Kuraray Co., Ltd. Kyowa Hakko Kogyo Co., Ltd. Mercian Corporation Mitsubishi Rayon Co., Ltd. Mitsui Chemicals, Inc. New Japan Chemical Co., Ltd. Nissan Chemical Industries.,Ltd. Nippon Fine Chemical Co., Ltd. Nippon Kayaku Co., Ltd. Nippon Nohyaku Co., Ltd. Nippon Shokubai Co., Ltd. Nippon Soda Co., Ltd. Nisshin Pharma Inc. Otsuka Chemical Co., Ltd. Shin-Etsu Chemical Co., Ltd. Soda Aromatic Co., Ltd. Sumika Fine Chemicals Co., Ltd. Sumikin Air Water Chemical Inc. Sumitomo Chemical Co., Ltd. Sumitomo Seika Chemicals Co., Ltd. Takasago International Corp. Tosoh Corporation The Nippon Synthetic Chemical Industry Co., Ltd. Ube Industries, Ltd. Yuki Gosei Kogyo Co., Ltd.The contents
- 1. Introduction
- 2. Summary
- 3. Case study (38 medium to large selected companies)
-
Headquarters
- Contact
- Founded
- Capital
- Employees
- Major shareholders
- Performance for Fiscal 2002: Non-consolidated (consolidated)
-
- Total sales
- R&D expenditures
- Net income
- Total asset
- Cash flow from operational activities
- Performance data by business/activity
- Core products and technologies related to pharmaceuticals
- Subsidiaries and affiliates related to pharmaceuticals (% invested)
Areas of Competence
Factories and Major Facilities
- Plant
-
- 1) Custom synthesis (cGMP-compliant)
- 2) Pilot facilities
- 3) Investigational drug production facilities